Related Experiment Video
Updated: Jun 4, 2026

Synthesis of Soft Polysiloxane-urea Elastomers for Intraocular Lens Application
Published on: March 8, 2019
Implantable phakic contact lens: vault evaluation 5 years postoperatively
Germán R Bianchi1, Andrés Paredes, Belén Puccio
1From the Clínica de Ojos Dr. Nano, Olivos, Buenos Aires, Argentina.
Purpose:
To evaluate the stability of the postoperative vault of the implantable phakic contact lens (IPCL) 5 years after implantation.
Setting:
Clínica de Ojos Dr. Nano, Olivos, Buenos Aires, Argentina.
Design:
Retrospective case-series study.
Methods:
Myopic patients operated with the IPCL for spherical correction in which preoperative data were compared with different scenarios of postoperative vault at 1, 3, and 5 years postoperatively. The main parameter to be evaluated was the vault obtained 5 years postoperatively.
Results:
140 eyes of 72 patients, aged 31.9 ± 2.8 years (21 to 50), were included. Most of the eyes (78.6%) obtained a vault between 250 μm and 750 μm, while in 15% of the eyes, it was less than 250 μm, and 6.4% were greater than 750 μm. The vault evaluated 1, 3, and 5 years postoperatively remained stable. Subcapsular cataracts were detected in 2 eyes, with vault <250 μm. A total of 50 eyes (35.7%) had cysts in the sulcus (5 cases in the group of eyes with vault >750 μm). No changes were detected in relation to intraocular pressure or endothelial cell count.
Conclusions:
In eyes implanted with the IPCL over 5 years, it was observed that the vault remained stable over time. The proportion of eyes with cysts was higher in eyes with vaults larger than 750 μm.
More Related Videos
04:59Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation
Published on: July 7, 2023
05:19Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery
Published on: December 1, 2023
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment